PubMed:18499864 / 895-1281 JSONTXT

Annnotations TAB JSON ListView MergeView

    Glycan-Motif

    {"project":"Glycan-Motif","denotations":[{"id":"T14","span":{"begin":251,"end":253},"obj":"https://glytoucan.org/Structures/Glycans/G00017MO"}],"text":"We used biotinylated GAGs and radio-iodinated streptavidin or AcLDL to assess the binding activities of ligands directly or indirectly (by competition with unlabeled ligands) in endocytosis assays using stable cell lines expressing the 315 or 190 kDa HA receptor for endocytosis (315- or 190-HARE) isoforms, and ELISA-like assays, with purified recombinant soluble 190-HARE ecto-domain."}

    GlyCosmos6-Glycan-Motif-Image

    {"project":"GlyCosmos6-Glycan-Motif-Image","denotations":[{"id":"T14","span":{"begin":251,"end":253},"obj":"Glycan_Motif"}],"attributes":[{"id":"A14","pred":"image","subj":"T14","obj":"https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G00017MO"}],"text":"We used biotinylated GAGs and radio-iodinated streptavidin or AcLDL to assess the binding activities of ligands directly or indirectly (by competition with unlabeled ligands) in endocytosis assays using stable cell lines expressing the 315 or 190 kDa HA receptor for endocytosis (315- or 190-HARE) isoforms, and ELISA-like assays, with purified recombinant soluble 190-HARE ecto-domain."}

    sentences

    {"project":"sentences","denotations":[{"id":"TextSentencer_T9","span":{"begin":0,"end":386},"obj":"Sentence"},{"id":"T8","span":{"begin":0,"end":386},"obj":"Sentence"},{"id":"T9","span":{"begin":0,"end":386},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"We used biotinylated GAGs and radio-iodinated streptavidin or AcLDL to assess the binding activities of ligands directly or indirectly (by competition with unlabeled ligands) in endocytosis assays using stable cell lines expressing the 315 or 190 kDa HA receptor for endocytosis (315- or 190-HARE) isoforms, and ELISA-like assays, with purified recombinant soluble 190-HARE ecto-domain."}

    uniprot-human

    {"project":"uniprot-human","denotations":[{"id":"T6","span":{"begin":292,"end":296},"obj":"http://www.uniprot.org/uniprot/Q8WWQ8"},{"id":"T7","span":{"begin":369,"end":373},"obj":"http://www.uniprot.org/uniprot/Q8WWQ8"},{"id":"T23","span":{"begin":251,"end":253},"obj":"http://www.uniprot.org/uniprot/P69208"}],"text":"We used biotinylated GAGs and radio-iodinated streptavidin or AcLDL to assess the binding activities of ligands directly or indirectly (by competition with unlabeled ligands) in endocytosis assays using stable cell lines expressing the 315 or 190 kDa HA receptor for endocytosis (315- or 190-HARE) isoforms, and ELISA-like assays, with purified recombinant soluble 190-HARE ecto-domain."}

    GlycoBiology-NCBITAXON

    {"project":"GlycoBiology-NCBITAXON","denotations":[{"id":"T6","span":{"begin":254,"end":266},"obj":"http://purl.bioontology.org/ontology/STY/T192"}],"text":"We used biotinylated GAGs and radio-iodinated streptavidin or AcLDL to assess the binding activities of ligands directly or indirectly (by competition with unlabeled ligands) in endocytosis assays using stable cell lines expressing the 315 or 190 kDa HA receptor for endocytosis (315- or 190-HARE) isoforms, and ELISA-like assays, with purified recombinant soluble 190-HARE ecto-domain."}

    GO-BP

    {"project":"GO-BP","denotations":[{"id":"T8","span":{"begin":178,"end":189},"obj":"http://purl.obolibrary.org/obo/GO_0006897"},{"id":"T9","span":{"begin":267,"end":278},"obj":"http://purl.obolibrary.org/obo/GO_0006897"},{"id":"T11","span":{"begin":82,"end":100},"obj":"http://purl.obolibrary.org/obo/GO_0051099"}],"text":"We used biotinylated GAGs and radio-iodinated streptavidin or AcLDL to assess the binding activities of ligands directly or indirectly (by competition with unlabeled ligands) in endocytosis assays using stable cell lines expressing the 315 or 190 kDa HA receptor for endocytosis (315- or 190-HARE) isoforms, and ELISA-like assays, with purified recombinant soluble 190-HARE ecto-domain."}

    GO-MF

    {"project":"GO-MF","denotations":[{"id":"T4","span":{"begin":104,"end":111},"obj":"http://purl.obolibrary.org/obo/GO_0005488"},{"id":"T5","span":{"begin":166,"end":173},"obj":"http://purl.obolibrary.org/obo/GO_0005488"},{"id":"T10","span":{"begin":82,"end":89},"obj":"http://purl.obolibrary.org/obo/GO_0070026"},{"id":"T21","span":{"begin":82,"end":89},"obj":"http://purl.obolibrary.org/obo/GO_0003680"},{"id":"T32","span":{"begin":82,"end":89},"obj":"http://purl.obolibrary.org/obo/GO_0017091"},{"id":"T43","span":{"begin":82,"end":89},"obj":"http://purl.obolibrary.org/obo/GO_0005488"}],"text":"We used biotinylated GAGs and radio-iodinated streptavidin or AcLDL to assess the binding activities of ligands directly or indirectly (by competition with unlabeled ligands) in endocytosis assays using stable cell lines expressing the 315 or 190 kDa HA receptor for endocytosis (315- or 190-HARE) isoforms, and ELISA-like assays, with purified recombinant soluble 190-HARE ecto-domain."}

    GO-CC

    {"project":"GO-CC","denotations":[{"id":"T1","span":{"begin":210,"end":214},"obj":"http://purl.obolibrary.org/obo/GO_0005623"}],"text":"We used biotinylated GAGs and radio-iodinated streptavidin or AcLDL to assess the binding activities of ligands directly or indirectly (by competition with unlabeled ligands) in endocytosis assays using stable cell lines expressing the 315 or 190 kDa HA receptor for endocytosis (315- or 190-HARE) isoforms, and ELISA-like assays, with purified recombinant soluble 190-HARE ecto-domain."}

    sentences

    {"project":"sentences","denotations":[{"id":"TextSentencer_T9","span":{"begin":0,"end":386},"obj":"Sentence"},{"id":"T8","span":{"begin":0,"end":386},"obj":"Sentence"},{"id":"T9","span":{"begin":0,"end":386},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"We used biotinylated GAGs and radio-iodinated streptavidin or AcLDL to assess the binding activities of ligands directly or indirectly (by competition with unlabeled ligands) in endocytosis assays using stable cell lines expressing the 315 or 190 kDa HA receptor for endocytosis (315- or 190-HARE) isoforms, and ELISA-like assays, with purified recombinant soluble 190-HARE ecto-domain."}

    GlyCosmos15-Sentences

    {"project":"GlyCosmos15-Sentences","blocks":[{"id":"T8","span":{"begin":0,"end":386},"obj":"Sentence"}],"text":"We used biotinylated GAGs and radio-iodinated streptavidin or AcLDL to assess the binding activities of ligands directly or indirectly (by competition with unlabeled ligands) in endocytosis assays using stable cell lines expressing the 315 or 190 kDa HA receptor for endocytosis (315- or 190-HARE) isoforms, and ELISA-like assays, with purified recombinant soluble 190-HARE ecto-domain."}